
GETAID
@PGetaid
Followers
352
Following
30
Media
35
Statuses
94
GETAID regroupe des centres de recherche français, belges, spécialisés dans la prise en charge des MICI. 🇫🇷 & 🇧🇪 centers dedicated to research in IBD.
Paris, France
Joined February 2022
Welcome to our dear Swiss colleagues !🚀🇨🇭🤝🇫🇷.
🌟Excited to announce that our Crohn’s and Colitis Center in Geneva has joined the GETAID ! 🌟 We look forward to collaborating to improve patient outcomes and quality of life through research and innovation. 🇫🇷🇨🇭. #IBD #Collaboration #CentreCrohnetColite @HopitaldeLaTour
0
1
5
En effet. Merci Laurent!.
Laurent Beaugerie was celebrated at the 5 Nations Meeting in IBD! A brilliant IBDologist, his groundbreaking contributions have significantly advanced clinical research 🎉👏 It's an honor to learn from him. Merci beaucoup, Laurent Beaugerie! #5NationsMeetinginIBD
0
0
2
❤️.
Excited to start the 5 Nations meeting in IBD! Representatives from France, Israel, Italy, Portugal, and Spain are coming together to exchange valuable knowledge and experiences in the field. Looking forward to fruitful discussions and collaborations. 🌍✨ #5NationsMeetinginIBD
0
0
8
RT @GEDII_IBD: The first day of 5 Nations ended with a bang! A taste of port wine on a cellar and a rooftop dinner! Today the work continue….
0
6
0
RT @alearmuzzi: 5 Nations is going to start…. Looking forward to be in Porto and start one of the best IBD advanced courses for young IBD f….
0
9
0
Enfin ! Une superbe avancée pour nos patients!.Écoutez notre président D. Laharie a ce sujet.
📢 Flash info : Hourra ! Il aura fallu plusieurs années de combat pour obtenir le remboursement de la calprotectine fécale et c'est chose faite !.Une belle victoire pour notre association et les personnes engagées à nos côtés ! 🙌.
0
1
6
Le @PGetaid présent a l’AFEMI pour la journée nationale d’éducation thérapeutique dans les MICI #ETP #empowerment
0
1
11
The new GETAID adventure #icare2.
Thanks to the hard work of the @GETAID clinical operation team and my colleague @J_Kirchgesner , 1st inclusion in the ICARE II study today! .ICAREII aimed to prospectively assess the safety of JAK i, anti-IL23, and S1p in real-life and their potential for disease modifications.
0
0
7
RT @PeyrinBiroulet: Informative collaborative study between @PGetaid and LYSA. "Lymphoma In Patients With Inflammatory Bowel Disease: A Mu….
0
4
0
RT @ZaherLakkis: We are thrilled to announce the publication in @JCC_IBD of 🇫🇷 nationwide study by @PGetaid Surgery Group, comparing the ef….
0
20
0